Evidence map›Paper›PMID 17235363›Full record

ArticlePloS one2007

Toxicity assays in nanodrops combining bioassay and morphometric endpoints.

Frédéric Lemaire, Céline A Mandon, Julien Reboud, Alexandre Papine, Jesus Angulo, Hervé Pointu, Chantal Diaz-Latoud, Christian Lajaunie, François Chatelain, André-Patrick Arrigo and 1 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
3.9field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Liver Cell Culture Devices.Cell medicine · 2010
    Article
  3. In vitro assessments of nanomaterial toxicity.Advanced drug delivery reviews · 2009
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 6 institutions in 1 country.

Frédéric LemaireCommissariat à l'Energie Atomique, DSV, Cellular Responses and Dynamics Department, Laboratoire Biopuces, Commissariat à l'Energie Atomique Centre de Grenoble, Grenoble, France.
Céline A Mandon
Julien Reboud
Alexandre Papine
Jesus Angulo
Hervé Pointu
Chantal Diaz-Latoud
Christian Lajaunie
François Chatelain
André-Patrick Arrigo
Béatrice Schaack
Commissariat à l'Énergie Atomique et aux Énergies Alternatives · FRCentre de Génétique Moléculaire · FRCEA Grenoble · FRCentre National de la Recherche Scientifique · FRÉcole Nationale Supérieure des Mines de Paris · FRImstar (France) · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundImproved chemical hazard management such as REACH policy objective as well as drug ADMETOX prediction, while limiting the extent of animal testing, requires the development of increasingly high throughput as well as highly pertinent in vitro toxicity assays. METHODOLOGY: This report describes a new in vitro method for toxicity testing, combining cell-based assays in nanodrop Cell-on-Chip format with the use of a genetically engineered stress sensitive hepatic cell line. We tested the behavior of a stress inducible fluorescent HepG2 model in which Heat Shock Protein promoters controlled Enhanced-Green Fluorescent Protein expression upon exposure to Cadmium Chloride (CdCl2), Sodium Arsenate (NaAsO2) and Paraquat. In agreement with previous studies based on a micro-well format, we could observe a chemical-specific response, identified through differences in dynamics and amplitude. We especially determined IC50 values for CdCl2 and NaAsO2, in agreement with published data. Individual cell identification via image-based screening allowed us to perform multiparametric analyses.

conclusionsUsing pre/sub lethal cell stress instead of cell mortality, we highlighted the high significance and the superior sensitivity of both stress promoter activation reporting and cell morphology parameters in measuring the cell response to a toxicant. These results demonstrate the first generation of high-throughput and high-content assays, capable of assessing chemical hazards in vitro within the REACH policy framework.

Indexed as

NanostructuresAnimalsArsenatesBiological AssayCadmium ChlorideCell DeathCell LineDose-Response Relationship, DrugEnvironmental PollutantsGene Expression RegulationGreen Fluorescent ProteinsHeat-Shock ProteinsHepatocytesHerbicidesHigh-Throughput Screening AssaysHumansArsenatesCadmium Chlorideenhanced green fluorescent proteinEnvironmental PollutantsGreen Fluorescent ProteinsHeat-Shock ProteinsHerbicidesParaquatsodium arsenate

Identifiers

PMID17235363
PMCPMC1769465
OpenAlexW1985980199

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.